JPH025736B2 - - Google Patents

Info

Publication number
JPH025736B2
JPH025736B2 JP51000736A JP73676A JPH025736B2 JP H025736 B2 JPH025736 B2 JP H025736B2 JP 51000736 A JP51000736 A JP 51000736A JP 73676 A JP73676 A JP 73676A JP H025736 B2 JPH025736 B2 JP H025736B2
Authority
JP
Japan
Prior art keywords
hepatitis
virus
antigen
liver
serum
Prior art date
Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
Expired - Lifetime
Application number
JP51000736A
Other languages
English (en)
Japanese (ja)
Other versions
JPS5283929A (en
Inventor
Jee Puroosuto Fuiritsupu
Eru Itensoon Osuwarudo
Aaru Hiruman Moorisu
Current Assignee (The listed assignees may be inaccurate. Google has not performed a legal analysis and makes no representation or warranty as to the accuracy of the list.)
Merck and Co Inc
Original Assignee
Merck and Co Inc
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Merck and Co Inc filed Critical Merck and Co Inc
Priority to JP73676A priority Critical patent/JPS5283929A/ja
Publication of JPS5283929A publication Critical patent/JPS5283929A/ja
Publication of JPH025736B2 publication Critical patent/JPH025736B2/ja
Granted legal-status Critical Current

Links

Classifications

    • Y—GENERAL TAGGING OF NEW TECHNOLOGICAL DEVELOPMENTS; GENERAL TAGGING OF CROSS-SECTIONAL TECHNOLOGIES SPANNING OVER SEVERAL SECTIONS OF THE IPC; TECHNICAL SUBJECTS COVERED BY FORMER USPC CROSS-REFERENCE ART COLLECTIONS [XRACs] AND DIGESTS
    • Y02—TECHNOLOGIES OR APPLICATIONS FOR MITIGATION OR ADAPTATION AGAINST CLIMATE CHANGE
    • Y02A—TECHNOLOGIES FOR ADAPTATION TO CLIMATE CHANGE
    • Y02A50/00—TECHNOLOGIES FOR ADAPTATION TO CLIMATE CHANGE in human health protection, e.g. against extreme weather
    • Y02A50/30—Against vector-borne diseases, e.g. mosquito-borne, fly-borne, tick-borne or waterborne diseases whose impact is exacerbated by climate change

Landscapes

  • Micro-Organisms Or Cultivation Processes Thereof (AREA)
  • Medicines Containing Antibodies Or Antigens For Use As Internal Diagnostic Agents (AREA)
JP73676A 1976-01-01 1976-01-01 Hepatisis a antigen Granted JPS5283929A (en)

Priority Applications (1)

Application Number Priority Date Filing Date Title
JP73676A JPS5283929A (en) 1976-01-01 1976-01-01 Hepatisis a antigen

Applications Claiming Priority (1)

Application Number Priority Date Filing Date Title
JP73676A JPS5283929A (en) 1976-01-01 1976-01-01 Hepatisis a antigen

Publications (2)

Publication Number Publication Date
JPS5283929A JPS5283929A (en) 1977-07-13
JPH025736B2 true JPH025736B2 (enrdf_load_stackoverflow) 1990-02-05

Family

ID=11481997

Family Applications (1)

Application Number Title Priority Date Filing Date
JP73676A Granted JPS5283929A (en) 1976-01-01 1976-01-01 Hepatisis a antigen

Country Status (1)

Country Link
JP (1) JPS5283929A (enrdf_load_stackoverflow)

Family Cites Families (2)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
JPS48103722A (enrdf_load_stackoverflow) * 1972-04-15 1973-12-26
US4029764A (en) * 1974-12-09 1977-06-14 Merck & Co., Inc. Hepatitis A antigen

Also Published As

Publication number Publication date
JPS5283929A (en) 1977-07-13

Similar Documents

Publication Publication Date Title
Russell et al. T cells primed by influenza virion internal components can cooperate in the antibody response to haemagglutinin
Gottlieb et al. Studies on macrophage RNA involved in antibody production.
Schaffer et al. Purification and properties of poliovirus
CA2197683C (en) Method for preparing an influenza virus, antigens obtained and applications thereof
US3636191A (en) Vaccine against viral hepatitis and process
US4029764A (en) Hepatitis A antigen
US4164565A (en) Vaccine for active immunization containing hepatitis B surface antigen and associated antigen
US4118478A (en) Vaccine manufacture for active immunization containing hepatitis B surface antigen and associated antigen
CA2348840A1 (en) Method for the production of an antiviral agent
US4031203A (en) Hepatitis A antigen
Houston et al. Adjuvant effects of diethylaminoethyl-dextran
US4118479A (en) Vaccine for active immunization containing hepatitis B surface antigen and associated antigen
Greig et al. Encephalomyelitis of swine caused by a haemagglutinating virus VI. Morphology of the virus
EP0120922B1 (en) Lectin-containing anti-viral vaccines for domestic animals and method of preparation
Furukawa et al. Studies on Hemagglutination by Rubella Virus.
EP0093438B1 (en) Non-a, non-b hepatitis antigen
Cho et al. The antigen and virus of Aleutian disease in mink
Brown Studies on the antigenic structure of herpes simplex virus
Iltis et al. Demonstration of an avian adenovirus as the causative agent of marble spleen disease
EP0005864B1 (en) Antigenic composition useful as a vaccine or vaccine intermediate, and process for preparing same
Rauscher Jr Virologic studies in human leukemia and lymphoma: The herpes-type virus
JPH025736B2 (enrdf_load_stackoverflow)
US4017601A (en) Hepatitis A antigen
Tzianabos et al. Origin and structure of the group-specific, complement-fixing antigen of Rickettsia rickettsii
CS223975B2 (en) Method of making the virus vaccines of the spring-summer meningoencephtalitide